Preview Mode Links will not work in preview mode

GRACEcast


Jan 29, 2016

Dr. Edward S. Kim from the Levine Cancer Institute in Charlotte, NC discusses the feasibility of molecular marker testing and targeted therapy in the adjuvant or post-operative setting.